Literature DB >> 7657810

Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth.

L E Greenbaum1, D E Cressman, B A Haber, R Taub.   

Abstract

During the period of rapid cell growth which follows a two-thirds partial hepatectomy, the liver is able to compensate for the acute loss of two-thirds of its mass to maintain serum glucose levels and many of its differentiation-specific functions. However certain hepatic transcription factors, C/EBP alpha and beta, which are important for establishment and maintenance of the differentiated state, have been shown to be antagonistic to cellular proliferation. To study the interplay between differentiation and cell growth in the liver regeneration model of hepatocyte proliferation, we characterized the expression of C/EBP alpha and beta transcription factors throughout the temporal course of liver regeneration. As determined by immunoblot, the level of C/EBP alpha decreases more than twofold during the mid to late G1 and S phase (8-24 h after hepatectomy) coordinately with a threefold increase in expression of C/EBP beta. Renormalization of the levels of these proteins occurs after the major proliferative phase. This inverse regulation of C/EBP alpha and beta results in up to a sevenfold increase in the beta / alpha DNA binding ratio between 3 and 24 h after hepatectomy that may have an important impact on target gene regulation. However, total C/EBP binding activity in nuclear extracts remains relatively constant during the 7-d period after hepatectomy. By immunohistochemistry, both C/EBP alpha and beta are expressed in virtually all hepatocyte nuclei throughout the liver during the temporal course of liver regeneration, and there is no exclusion of expression from hepatocytes that are expressing immediate-early gene products or undergoing DNA synthesis. The persistent expression of C/EBP alpha and beta isoforms predicts that C/EBP proteins contribute to the function of hepatocytes during physiologic growth and that significant amounts of these proteins do not inhibit progression of hepatocytes into S phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657810      PMCID: PMC185757          DOI: 10.1172/JCI118170

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor.

Authors:  Y H Lee; M Yano; S Y Liu; E Matsunaga; P F Johnson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

2.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.

Authors:  B Stein; P C Cogswell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

3.  CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials.

Authors:  V Ossipow; P Descombes; U Schibler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

4.  Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain.

Authors:  C Trautwein; C Caelles; P van der Geer; T Hunter; M Karin; M Chojkier
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

5.  Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats.

Authors:  P Flodby; P Antonson; C Barlow; A Blanck; I Porsch-Hällström; K G Xanthopoulos
Journal:  Exp Cell Res       Date:  1993-09       Impact factor: 3.905

6.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.

Authors:  B Stein; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

7.  A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity.

Authors:  F T Lin; O A MacDougald; A M Diehl; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

8.  The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain.

Authors:  K J Wu; D R Wilson; C Shih; G J Darlington
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

9.  Determination of tissue specificity of the enhancer by combinatorial operation of tissue-enriched transcription factors. Both HNF-4 and C/EBP beta are required for liver-specific activity of the ornithine transcarbamylase enhancer.

Authors:  A Nishiyori; H Tashiro; A Kimura; K Akagi; K Yamamura; M Mori; M Takiguchi
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region.

Authors:  W Hsu; T K Kerppola; P L Chen; T Curran; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

View more
  31 in total

1.  HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver.

Authors:  K Du; Y Peng; L E Greenbaum; B A Haber; R Taub
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

2.  Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration.

Authors:  Jingmin Shu; Betsy T Kren; Zhilian Xia; Phillip Y-P Wong; Lihua Li; Eric A Hanse; Michael X Min; Bingshan Li; Jeffrey H Albrecht; Yan Zeng; Subbaya Subramanian; Clifford J Steer
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

Review 3.  Liver regeneration: biological and pathological mechanisms and implications.

Authors:  George K Michalopoulos; Bharat Bhushan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-06       Impact factor: 46.802

4.  Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.

Authors:  Bowen Liu; Aaron W Bell; Shirish Paranjpe; William C Bowen; Jaspal S Khillan; Jian-Hua Luo; Wendy M Mars; George K Michalopoulos
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats.

Authors:  Shirish Paranjpe; William C Bowen; George C Tseng; Jian-Hua Luo; Anne Orr; George K Michalopoulos
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

6.  CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy.

Authors:  L E Greenbaum; W Li; D E Cressman; Y Peng; G Ciliberto; V Poli; R Taub
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  p21 is required for dextrose-mediated inhibition of mouse liver regeneration.

Authors:  Alexander Weymann; Eric Hartman; Vered Gazit; Connie Wang; Martin Glauber; Yumirle Turmelle; David A Rudnick
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

8.  Adipogenic potential can be activated during muscle regeneration.

Authors:  Akira Wagatsuma
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

9.  The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival.

Authors:  James Y Dai; Marie C DeFrances; Chunbin Zou; Carla J Johnson; Reza Zarnegar
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

10.  Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation.

Authors:  Julia I Leu; Mary Ann S Crissey; Linden E Craig; Rebecca Taub
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.